Moneycontrol PRO
Loans
Loans
HomeNewscoronavirusICMR pitches for pooling samples for COVID-19 testing in areas with less than 2% positive cases

ICMR pitches for pooling samples for COVID-19 testing in areas with less than 2% positive cases

"It has been demonstrated that performing real-time PCR for COVID-19 by pooling 5 samples of TS/NS is feasible when the prevalence rates of infection are low," the council's advisory says.

April 14, 2020 / 18:25 IST

Indian Council of Medical Research (ICMR), the apex medical body, released an advisory for using pooled samples to increase the capacity of laboratories to screen more samples using molecular testing for COVID-19 and for the purpose of surveillance.

A pooled testing algorithm involves the reverse transcription polymerase chain reaction (RT-PCR) screening of multiple individual patient samples pooled together. If the test is positive, all persons are tested individually. This is called pool de-convolution.

If all individual samples in a negative pool are regarded as negative, it results in substantial cost savings when a large proportion of pools tests negative.

This method can greatly enhance the capacity to test in a low-resources setting, as RT-PCR test is reliable but not scalable. Also, when positive cases are still low, it may help to use the pooled samples for screening.

Pooling conditions

A feasibility study was conducted at DHR/ICMR Virus Research and Diagnostic Laboratory (VRDL) at King George’s Medical University (KGMU), Lucknow.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"It has been demonstrated that performing real-time PCR for COVID-19 by pooling 5 samples of TS/NS (200 ul/sample) is feasible when the prevalence rates of infection are low," the advisory said.

"All individual samples in a negative pool to be regarded as negative. Deconvoluted testing is recommended if any of the pool is positive. Pooling of more than 5 samples is not recommended to avoid the effect of dilution leading to false negatives," the advisory added.

The other conditions that ICMR has set forward include the use of pooling only in areas with a low prevalence of COVID-19 or positivity of less than 2 percent from the existing data. Still, a watch should be kept on increasing positivity in such areas.

In the areas with positivity of 2-5 percent, sample pooling for PCR screening may be considered only in community survey or surveillance among asymptomatic individuals, strictly excluding pooling samples of individuals with known contact with confirmed cases, health care workers in direct contact with care of COVID-19 patients. Sample from such individuals should be directly tested without pooling.

The pooling of samples is not recommended in areas or populations with positivity rates of 5 percent for COVID-19.

Preferable number of samples to be pooled is five, though more than two samples can be pooled, but considering the higher possibility of missing positive samples with low viral load, it strongly discouraged to pool more than 5 samples, except in research mode.

It is still not clear whether the pooling is allowed in private labs or not.

Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Apr 14, 2020 06:25 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347